VRDN EBITDA Margin
Viridian Therapeutics Ors Inc · EBITDA Margin
VRDN EBITDA Margin
Latest reported-41794.01%period ending
VRDN Quarterly EBITDA Margin (-3.67% → -41794.01%)
Quarterly ebitda margin
High-resolution chart · PNG
VRDN ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -41,794.0141% | |
| -71,856.7376% | |
| -86,081.0606% | |
| -48.0785% | |
| -133,477.3333% | |
| -119,734.7222% | |
| -109,366.6667% | |
| -87,854.6512% | |
| -89,241.6667% | |
| -66,402.7778% | |
| -91,380.5556% | |
| -65,173.6111% | |
| -76,062.5% | |
| -69,266.3265% | |
| -43,353.3333% | |
| -2,399.9163% | |
| -11,437.5% | |
| -11,830.0926% | |
| -13,509.8131% | |
| -6,737.0192% | |
| -1,645.7798% | |
| -1,273.7422% | |
| -38,309.2593% | |
| 0% | |
| -3,736.3095% | |
| -946.256% | |
| -908.8636% | |
| -1,576.259% | |
| -341.9252% | |
| -3,044.086% | |
| -2,103.7815% | |
| -920.4449% | |
| -384.9679% | |
| -91.6179% | |
| -513.0034% | |
| -348.0074% | |
| -995.5432% | |
| -1,479.6537% | |
| -727.1164% | |
| -198.9876% | |
| -284.2105% | |
| -334.3521% | |
| -469.4992% | |
| -614.9701% | |
| -333.1063% | |
| -397.9845% | |
| -338.9194% | |
| -122.9064% | |
| -217.9078% | |
| -12.0082% | |
| 26.7283% | |
| -27.93% | |
| -2.0746% | |
| -3.6687% |